Mounjaro Before Embryo Transfer: Timing, Safety and What Prescribers Advise

Step 1: Have the conversation with both your fertility team and your prescriber before anything changes

The first practical step is not stopping Mounjaro. It is making sure the right people know about your plans. Your fertility consultant and your prescribing clinician need to be talking from the same page, because the timing of stopping tirzepatide, the length of any wash-out, and whether treatment can be restarted after a transfer all depend on your individual circumstances.

Tirzepatide works by slowing gastric emptying and reducing appetite via dual GIP and GLP-1 receptor activation. It is licensed in the UK for weight management and type 2 diabetes in adults, as the NHS tirzepatide medicines page explains. But that licence specifically excludes pregnancy, and the SmPC advises against use in women who are pregnant, breastfeeding, or planning to conceive. That guidance is the starting point for every conversation about IVF timing.

If you are already receiving Mounjaro through a private prescriber, flagging your fertility plans at your next review is essential. At nume, every repeat order is clinically re-reviewed; a change in your reproductive plans is exactly the kind of update that shapes what happens next.

Step 2: Understand why a wash-out period matters before transfer

The reason fertility teams ask patients to stop tirzepatide before an embryo transfer is precautionary. There is limited human safety data for tirzepatide in early pregnancy, and animal reproductive toxicity studies identified risks at doses used in trials. The MHRA's position, reflected in the product's Summary of Product Characteristics, is that it should not be used during pregnancy. That makes stopping before a planned transfer a reasonable clinical step, not an overcaution.

The length of the wash-out is something your fertility team will advise on specifically, it is not fixed in the same way for every patient. What matters is that you build this into your planning early, rather than discovering the question a week before egg collection or transfer. Some patients going through IVF have already used the treatment period to reduce their BMI ahead of their cycle, which can itself have clinical value; research on obesity and IVF outcomes is discussed in detail on our page covering what meaningful weight change on tirzepatide looks like.

Practical note: if you order Mounjaro before 12pm on a weekday and your prescriber approves the repeat, it dispatches the same day. That speed works in your favour when you need to plan a final prescription before a treatment pause, but the pause itself is clinically directed, not a logistics question.

Step 3: Know what stopping Mounjaro involves in practice

Stopping tirzepatide is not medically complicated, but it does affect appetite. Many people find hunger returns noticeably in the weeks after stopping, particularly at higher maintenance doses. That is a normal pharmacological effect, the medicine's appetite-regulating action fades as it clears your system. Being aware of this ahead of a cycle, and planning meals and protein intake with it in mind, is useful.

The NHS England guidance on weight-management injections covers several related practical points, including contraception considerations during treatment, relevant for anyone managing their reproductive health alongside a GLP-1 medicine. For women on oral contraceptives who have been taking tirzepatide, there is specific guidance about pill absorption that is worth reviewing with your prescriber before any cycle begins.

You can also read about what to do before taking Mounjaro for a broader look at the practical steps involved. And if you have questions about how the medicine is taken day-to-day alongside other health considerations, the nume FAQs are a useful starting point before a prescriber conversation.

Step 4: Restarting after a transfer, what is and is not known

Whether and when to restart Mounjaro after an embryo transfer depends entirely on what comes next. If the transfer results in pregnancy, tirzepatide should not be restarted, the not-recommended guidance applies throughout gestation and during breastfeeding. If the cycle is unsuccessful, restarting is a clinical decision made with your prescriber once you and your fertility team are ready to plan the next steps.

There is no blanket rule that a person cannot use Mounjaro again after an unsuccessful transfer cycle. But any restart means a fresh clinical review, a reassessment of your current weight and health picture, and a considered view on timing relative to any future planned cycle. That review is not a formality. A question our prescribers hear regularly in this context is whether previous results are a reliable guide to what a new cycle of treatment would achieve, and reading about what Mounjaro before and after looks like for real patients can give useful context, even if bodies, circumstances and timing all change.

If you are at the earlier stage of thinking about what tirzepatide involves before any fertility planning, our tirzepatide overview covers the medicine's mechanism and clinical profile. Patients who want to know what to do before starting Mounjaro will find guidance on preparing well for treatment, and for anyone wondering about whether to take Mounjaro before bed, that page covers timing considerations in practical detail. For a broader view of the weight-loss treatment options available at nume, our treatments page gives the full picture. When you are ready to speak to a clinician directly, starting a free consultation is the right next step.